Related Experiment Video
Updated: Feb 7, 2026

A Combined 3D Tissue Engineered In Vitro/In Silico Lung Tumor Model for Predicting Drug Effectiveness in Specific Mutational Backgrounds
Published on: April 6, 2016
Combining clinical predictors to better predict for the no-reflow phenomenon
1Cardiology Department, Balikesir University, Faculty of Medicine, Balikesir, Turkey. dreyupavci@gmail.com.
Insights
Combining the CHA2DS2-VASc score with a pre-percutaneous coronary intervention (PCI) thrombus load score improves detection of the no-reflow phenomenon in ST-elevation myocardial infarction (STEMI) patients undergoing primary PCI. This combined approach offers enhanced sensitivity for identifying no-reflow compared to using either score alone.
Area of Science:
- Cardiology
- Interventional Cardiology
- Clinical Research
Background:
- The no-reflow phenomenon is a complication following primary percutaneous coronary intervention (PPCI) for acute ST-elevation myocardial infarction (STEMI).
- Predicting no-reflow is crucial for optimizing patient outcomes after PPCI.
- Existing scoring systems like CHA2DS2-VASc and thrombus load scores have limitations in predicting no-reflow independently.
Purpose of the Study:
- To evaluate the sensitivity of a combined CHA2DS2-VASc score and pre-PCI thrombus load score in detecting the no-reflow phenomenon.
- To compare the predictive accuracy of the combined score against the CHA2DS2-VASc score alone and the thrombus load score alone.
- To assess the added value of the thrombus load score to the CHA2DS2-VASc score in STEMI patients undergoing PPCI.
Main Methods:
- A cohort of 497 patients with acute STEMI undergoing PPCI were analyzed.
- Patients were categorized into no-reflow (n=194) and control (n=303) groups based on Thrombolysis In Myocardial Infarction (TIMI) flow grading and Myocardial Blush Grade (MBG).
- Statistical analysis compared the predictive performance (AUC, net reclassification improvement) of the CHA2DS2-VASc score alone, thrombus load score alone, and their combination.
Main Results:
- The no-reflow group exhibited significantly higher CHA2DS2-VASc scores and pre-PCI thrombus load scores compared to the control group.
- The combined score demonstrated superior sensitivity in predicting no-reflow compared to the CHA2DS2-VASc score alone (AUC 0.65 vs. 0.60, p < 0.05).
- The addition of the pre-PCI thrombus load score to the CHA2DS2-VASc score resulted in significant net reclassification improvement (6.7%, p = 0.047).
Conclusions:
- The combination of CHA2DS2-VASc score and pre-PCI thrombus load score is more sensitive for detecting the no-reflow phenomenon in STEMI patients undergoing PPCI.
- This combined scoring system offers improved predictive accuracy for no-reflow compared to using individual scores.
- Integrating thrombus burden assessment with clinical risk factors enhances the prediction of post-PPCI no-reflow.
Objective:
We aimed to determine whether the combination of a CHA2DS2-VASc score (C: Congestive Heart Failure, H: Hypertension, A2: Age ≥ 75 years, D: Diabetes mellitus, S: Stroke history, V: Vascular disease, A: Age ≥ 65 years, Sc: Sex category) and pre-percutaneous coronary intervention (PCI) thrombus load score was more sensitive at detecting the no-reflow phenomenon compared to the CHA2DS2-VASc score alone or to the thrombus load score alone in patients with acute ST-elevation myocardial infarction (STEMI) who had underwent primary PCI (PPCI).
Patients And Methods:
497 patients with acute STEMIs were divided into two groups: no-reflow group (n: 194) and control group (n: 303). The Thrombolysis In Myocardial Infarction (TIMI) flow grading and Myocardial Blush Grade (MBG) were used together to define angiographic no-reflow as TIMI flow < 3 (with any MBG grade) or TIMI flow 3 with MBG 0 or 1. Successful reperfusion was defined as TIMI flow 3 with MBG 2 or 3.
Results:
CHA2DS2-VASc score was significantly higher in the no-reflow group than in the control group (2 [1-4] vs. 1 [0-3], p < 0.001]. Compared with the control group, the no-reflow group had a higher pre-PCI thrombus score (5 [4-5] vs. 4 [3-5], p = 0.001). Compared with the CHA2DS2-VASc score alone, the combined use of the pre-PCI thrombus score and the CHA2DS2-VASc score was associated with significant improvements in the ability to predict no-reflow (AUC) (0.65 vs. 0.60, p < 0.05). The addition of the pre-PCI thrombus score to the CHA2DS2-VASc score was related to a significant net reclassification improvement of 6.7% (p = 0.047) and an integrated discrimination improvement of 0.036 (p < 0.05).
Conclusions:
We have found that the combination of a CHA2DS2-VASc score and a pre-PCI thrombus load score was more sensitive in detecting the no-reflow phenomenon than only a CHA2DS2-VASc score in patients who underwent PPCIs for STEMIs.
Related Concept Videos
Tip-of-the-Tongue Phenomenon
Predicting Molecular Geometry
Prediction Intervals
However, the point estimate is most likely not the exact value of the population parameter, but close to it. After calculating point estimates, we construct interval estimates, called confidence intervals or prediction intervals. This prediction interval comprises a range of values unlike the point estimate and is a better predictor of the observed sample value, y.
End Point Prediction: Gran Plot
For potentiometric titration, the Gran plot is created by plotting...
Sensitivity, Specificity, and Predicted Value
Sensitivity is the...
Predicting Reaction Outcomes

